Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document
 Download Full Day's HansardDownload Full Day's Hansard    View Or Save XMLView/Save XML

Previous Fragment    Next Fragment
Thursday, 4 April 1957


Mr Whitlam m asked the Minister for Health, upon notice -

1.   Is reserpine regarded, as stated by the Minislei for External Affairs in this House, on 25th May, 1955, as valuable in the treatment of high blood pressure and hypertension?

2.   ls reserpine marketed under the trade name Serpasil?

3.   Has the Pharmaceutical Benefits Advisory Committee considered the listing of Serpasil as si pharmaceutical benefit under the National Health Act?

4.   If so, what was the date and text of the committee's recommendation?


Dr DONALD CAMERON (OXLEY, QUEENSLAND) - The answers to the honorable member's questions are as follows: -

1.   Yes.

2.   Yes.

3.   Yes.

4.   Any decision arrived at will only be made after consideration of the committee's recommendation.







Suggest corrections